OpenProtein.AI Expands Strategic Partnership with Boehringer Ingelheim to Advance AI-Driven Antibody Discovery
Boehringer Ingelheim expands its collaboration with OpenProtein.AI following successful initial deployment, co-developing integrated workflows for next-generation therapeutic development. NEW YORK, March 31, 2026 /PRNewswire/ -- OpenProtein.AI, a leader in AI-powered protein engineering...
CP
cision pr newswire
via Pr Newswire
Updated 2h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Trump Hits Out at France For Closing Airspace to US Military
Next

